Almendro V - Search Results

1

Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.

Almendro V, Cheng YK, Randles A, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz M, Russnes HG, Helland A, Rye IH, Borresen-Dale AL, Maruyama R, van Oudenaarden A, Dowsett M, Jones RL, Reis-Filho J, Gascon P, Gönen M, Michor F, Polyak K. Almendro V, et al. Cell Rep. 2014 Feb 13;6(3):514-27. doi: 10.1016/j.celrep.2013.12.041. Epub 2014 Jan 23. Cell Rep. 2014. PMID: 24462293 Free PMC article.

2

Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.

Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametller E, Argilés JM, López-Soriano FJ. Busquets S, et al. Among authors: almendro v. Cancer Res. 2004 Sep 15;64(18):6725-31. doi: 10.1158/0008-5472.CAN-04-0425. Cancer Res. 2004. PMID: 15374990

3

Interleukin-15 decreases lipid intestinal absorption.

Almendro V, Carbó N, Busquets S, López-Soriano J, Figueras M, Ametller E, Argilés JM, López-Soriano FJ. Almendro V, et al. Int J Mol Med. 2005 Jun;15(6):963-7. Int J Mol Med. 2005. PMID: 15870900

4

Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.

Fuster G, Busquets S, Ametller E, Olivan M, Almendro V, de Oliveira CC, Figueras M, López-Soriano FJ, Argilés JM. Fuster G, et al. Among authors: almendro v. Cancer Res. 2007 Jul 1;67(13):6512-9. doi: 10.1158/0008-5472.CAN-07-0231. Cancer Res. 2007. PMID: 17616713

5

Effects of IL-15 on rat brown adipose tissue: uncoupling proteins and PPARs.

Almendro V, Fuster G, Busquets S, Ametller E, Figueras M, Argilés JM, López-Soriano FJ. Almendro V, et al. Obesity (Silver Spring). 2008 Feb;16(2):285-9. doi: 10.1038/oby.2007.47. Obesity (Silver Spring). 2008. PMID: 18239634 Free article.

6

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin.

Almendro V, Ametller E, García-Recio S, Collazo O, Casas I, Augé JM, Maurel J, Gascón P. Almendro V, et al. PLoS One. 2009;4(3):e4728. doi: 10.1371/journal.pone.0004728. Epub 2009 Mar 6. PLoS One. 2009. PMID: 19266094 Free PMC article.

7

Interleukin-15 increases calcineurin expression in 3T3-L1 cells: possible involvement on in vivo adipocyte differentiation.

Almendro V, Fuster G, Ametller E, Costelli P, Pilla F, Busquets S, Figueras M, Argilés JM, López-Soriano FJ. Almendro V, et al. Int J Mol Med. 2009 Oct;24(4):453-8. doi: 10.3892/ijmm_00000252. Int J Mol Med. 2009. PMID: 19724884

8

Tumor promoting effects of CD95 signaling in chemoresistant cells.

Ametller E, García-Recio S, Costamagna D, Mayordomo C, Fernández-Nogueira P, Carbó N, Pastor-Arroyo EM, Gascón P, Almendro V. Ametller E, et al. Among authors: almendro v. Mol Cancer. 2010 Jun 23;9:161. doi: 10.1186/1476-4598-9-161. Mol Cancer. 2010. PMID: 20573240 Free PMC article.

9

Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death.

Ametller E, García-Recio S, Pastor-Arroyo EM, Callejo G, Carbó N, Gascón P, Almendro V. Ametller E, et al. Among authors: almendro v. Cancer Biol Ther. 2011 Jan 1;11(1):4-13. doi: 10.4161/cbt.11.1.13672. Epub 2011 Jan 1. Cancer Biol Ther. 2011. PMID: 20980803

10

Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2.

Mayordomo C, García-Recio S, Ametller E, Fernández-Nogueira P, Pastor-Arroyo EM, Vinyals L, Casas I, Gascón P, Almendro V. Mayordomo C, et al. Among authors: almendro v. J Cell Physiol. 2012 Apr;227(4):1358-66. doi: 10.1002/jcp.22848. J Cell Physiol. 2012. PMID: 21604273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page